Clinical and Molecular Hepatology

"Cohort study"

Letters to the Editor

Letter to the editor on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study”: Meng-Che Wu, Hui-Chin Chang, Yi-Sheng Jhang, Shuo-Yan Gau; Clin Mol Hepatol 2025;31(1):e13-e14.
Published online September 2, 2024; DOI: https://doi.org/10.3350/cmh.2024.0682

Citations

Citations to this article as recorded by

Correspondence to letter to the editor on “Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study”
Young Eun Chon, Dong Yun Kim, Hong Jae Chon, Do Young Kim
Clinical and Molecular Hepatology.2025; 31(1): e98. CrossRef

Non-alcoholic fatty liver disease and risk of dementia: Unmet need for a pooled analysis of cohort studies: Seogsong Jeong, Won Kim, Sang Min Park; Clin Mol Hepatol 2022;28(4):933-934.
Published online September 14, 2022; DOI: https://doi.org/10.3350/cmh.2022.0267

Citations

Citations to this article as recorded by

Lean Metabolic Dysfunction-Associated Steatotic Liver Disease and Dementia Risk: A High-Risk Phenotype beyond Body Mass Index
Seogsong Jeong
Gut and Liver.2026; 20(1): 3. CrossRef
A Mediterranean-style diet protects against cognitive and behavioral deficits, adiposity, and Alzheimer's disease-related markers, compared to a macronutrient-matched typical American diet in C57BL/6J mice
Paige N Braden-Kuhle, Vivienne A Lacy, Kelly N Brice, Morgan E Bertrand, Hatice Buse Uras, Catherine Shoffner, Bridgette E Fischer, Ashish Rana, Jada L Willis, Gary W Boehm, Michael J Chumley
Journal of Alzheimer’s Disease.2025; 104(3): 678. CrossRef